Literature DB >> 16843178

Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.

Sun H Kim1, Lubna Chunawala, Randolph Linde, Gerald M Reaven.   

Abstract

OBJECTIVES: The goals of this study were to assess the effect of the 2003 American Diabetes Association definition of impaired fasting glucose (IFG) on prevalence of IFG, coronary heart disease (CHD) risk factors, and CHD compared with the 1997 IFG definition.
BACKGROUND: Although IFG is viewed as increasing CHD risk, this association is unclear and has not been well studied after changing the IFG criterion, especially in a clinical practice setting.
METHODS: This was a cross-sectional evaluation of 8,295 members (3,763 men and 4,532 women) of a community medical center who were between the ages of 30 and 69 years, without a history of diabetes mellitus, and who had available measurements of fasting plasma glucose and lipid concentrations within the past 2 years. The prevalence of IFG, CHD risk factors, and CHD with the 1997 and 2003 IFG definition was compared.
RESULTS: The prevalence of IFG increased from 8% to 35% with the 2003 criterion. Individuals with glucose of 100 to 109 mg/dl had lower prevalence of most CHD risk factors (hypertension, triglyceride > or =150 mg/dl, high-density lipoprotein cholesterol <40 mg/dl, meeting 2 components of the metabolic syndrome criteria, CHD risk > or =10% by Framingham score) compared with individuals with glucose 110 to 125 mg/dl. Individuals identified with the 2003 IFG definition did not have an increase in known CHD when adjusted for covariates (odds ratio 1.4 [95% confidence interval (CI) 0.7 to 2.3] vs. 3.2 [95% CI 1.8 to 5.9]).
CONCLUSIONS: One-third of the population has IFG with the 2003 definition, yet many of these individuals do not have increased prevalence of CHD risk factors or CHD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16843178     DOI: 10.1016/j.jacc.2006.03.043

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Joseph Yeboah; Alain G Bertoni; David M Herrington; Wendy S Post; Gregory L Burke
Journal:  J Am Coll Cardiol       Date:  2011-07-05       Impact factor: 24.094

Review 2.  Male infertility and somatic health - insights into lipid damage as a mechanistic link.

Authors:  Nathan D Burke; Brett Nixon; Shaun D Roman; John E Schjenken; Jessica L H Walters; R John Aitken; Elizabeth G Bromfield
Journal:  Nat Rev Urol       Date:  2022-09-13       Impact factor: 16.430

Review 3.  [The unsolved problem of diabetes mellitus type 2 and associated complications].

Authors:  M Morcos; P Humpert; A Bierhaus; P Nawroth
Journal:  Chirurg       Date:  2009-05       Impact factor: 0.955

4.  Is male fertility associated with type 2 diabetes mellitus?

Authors:  Abdulbari Bener; Abdulla A Al-Ansari; Mahmoud Zirie; Abdulla O A A Al-Hamaq
Journal:  Int Urol Nephrol       Date:  2009-04-21       Impact factor: 2.370

5.  Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: observations from the Dallas Heart Study.

Authors:  Frank Y F Xing; Ian J Neeland; M Odette Gore; Colby R Ayers; Andre R M Paixao; Aslan T Turer; Jarett D Berry; Amit Khera; James A de Lemos; Darren K McGuire
Journal:  Diab Vasc Dis Res       Date:  2014-01       Impact factor: 3.291

6.  Race and ethnicity, obesity, metabolic health, and risk of cardiovascular disease in postmenopausal women.

Authors:  Michelle D Schmiegelow; Haley Hedlin; Rachel H Mackey; Lisa W Martin; Mara Z Vitolins; Marcia L Stefanick; Marco V Perez; Matthew Allison; Mark A Hlatky
Journal:  J Am Heart Assoc       Date:  2015-05-20       Impact factor: 5.501

7.  Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes.

Authors:  Sun H Kim; Fahim Abbasi; Cindy Lamendola; Alice Liu; Danit Ariel; Patricia Schaaf; Kaylene Grove; Vanessa Tomasso; Hector Ochoa; Yeheng V Liu; Yii-Der Ida Chen; Gerald Reaven
Journal:  Diabetes Care       Date:  2013-07-08       Impact factor: 19.112

Review 8.  Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis.

Authors:  Yuli Huang; Xiaoyan Cai; Weiyi Mai; Meijun Li; Yunzhao Hu
Journal:  BMJ       Date:  2016-11-23

9.  Risk of Coronary Heart Disease in Different Criterion of Impaired Fasting Glucose: A Meta-Analysis.

Authors:  Tianyu Xu; Wangkai Liu; Xiaoyan Cai; Jian Ding; Hongfeng Tang; Yuli Huang; Yunzhao Hu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

10.  Feasibility of Ideal Cardiovascular Health Evaluation in a Pediatric Clinic Setting.

Authors:  Piers Blackett; Kerry Farrell; Minh Truong; Minu George; Peggy Turner; Joane Less; Jonathan D Baldwin; Allen W Knehans
Journal:  Adv Prev Med       Date:  2018-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.